Arsenic compounds: The wide application and mechanisms applied in acute promyelocytic leukemia and carcinogenic toxicology
Guangzhi Liu,Yurong Song,Chenxi Li,Rui Liu,Youwen Chen,Liuchunyang Yu,Qingcai Huang,Dongjie Zhu,Cheng Lu,Xue Yu,Cheng Xiao,Yuanyan Liu
DOI: https://doi.org/10.1016/j.ejmech.2021.113519
IF: 7.088
2021-10-01
European Journal of Medicinal Chemistry
Abstract:<p>Arsenic (As), as well as its various compounds have been widely used for nearly 4,000 years either as drugs or poisons. These compounds are valuable in the treatment of various diseases ranging from dermatosis to cancer, thereby emphasizing their important roles as therapeutic agents. The ability of <strong>As</strong> compounds, especially arsenic trioxide (ATO) in the treatment of acute promyelocytic leukemia (APL), has fundamentally altered people's understanding of the poison, and has become a major factor in the re-emergence of Western medicine candidates to treat leukemia and other solid tumors. However, long-term exposure to <strong>As</strong> has been correlated with numerous disadvantageous influences on health, particularly carcinogenesis. Importantly, accumulating evidence suggests that biotransformation of As, as a step to eliminate <strong>As</strong> from the human body, can induce alterations at the genetic and epigenetic levels, resulting in therapeutic effects or carcinogenesis. In this article, we aimed to provide a systematic overview of the primary contributions associated with <strong>As</strong> and its compounds, as well as the detailed mechanisms applied in APL cells and carcinogenic toxicology. This review may help to understand the underlying mechanisms and safe wide clinical applications of medicinal As along with its compounds.</p>
chemistry, medicinal